Oncology Institute (TOIIW) Competitors $0.02 -0.01 (-23.15%) As of 04/10/2025 03:58 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsInsider TradesSEC FilingsShort InterestTrendsBuy This Stock TOIIW vs. ACONW, AONC, DHACW, LFMDP, OTRKP, PIIIW, TALKW, NTRA, FMS, and HIMSShould you be buying Oncology Institute stock or one of its competitors? The main competitors of Oncology Institute include Aclarion (ACONW), American Oncology Network (AONC), Digital Health Acquisition (DHACW), LifeMD (LFMDP), Ontrak (OTRKP), P3 Health Partners (PIIIW), Talkspace (TALKW), Natera (NTRA), Fresenius Medical Care (FMS), and Hims & Hers Health (HIMS). These companies are all part of the "healthcare" industry. Oncology Institute vs. Aclarion American Oncology Network Digital Health Acquisition LifeMD Ontrak P3 Health Partners Talkspace Natera Fresenius Medical Care Hims & Hers Health Aclarion (NASDAQ:ACONW) and Oncology Institute (NASDAQ:TOIIW) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, profitability, valuation, risk, analyst recommendations, earnings, community ranking, dividends and institutional ownership. Does the media favor ACONW or TOIIW? In the previous week, Aclarion and Aclarion both had 1 articles in the media. Oncology Institute's average media sentiment score of 1.89 beat Aclarion's score of 1.87 indicating that Oncology Institute is being referred to more favorably in the news media. Company Overall Sentiment Aclarion Very Positive Oncology Institute Very Positive Is ACONW or TOIIW more profitable? Company Net Margins Return on Equity Return on Assets AclarionN/A N/A N/A Oncology Institute N/A N/A N/A Does the MarketBeat Community prefer ACONW or TOIIW? Aclarion and Oncology Institute both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformAclarionN/AN/AOncology InstituteN/AN/A Which has higher valuation and earnings, ACONW or TOIIW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAclarion$49.29KN/AN/AN/AN/AOncology Institute$393.41MN/AN/AN/AN/A SummaryOncology Institute beats Aclarion on 2 of the 2 factors compared between the two stocks. Remove Ads Get Oncology Institute News Delivered to You Automatically Sign up to receive the latest news and ratings for TOIIW and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TOIIW vs. The Competition Export to ExcelMetricOncology InstituteMedical Care Facilities IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$1.41B$5.17B$7.38BDividend YieldN/A3.83%5.35%4.26%P/E RatioN/A6.7021.7617.55Price / SalesN/A15.09351.8589.69Price / CashN/A12.5138.1534.64Price / BookN/A1.796.163.81Net IncomeN/A$58.65M$3.19B$247.05M7 Day PerformanceN/A-1.70%-0.09%0.58%1 Month PerformanceN/A-3.41%-2.89%-8.66%1 Year PerformanceN/A5.25%2.66%-6.60% Oncology Institute Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TOIIWOncology InstituteN/A$0.02-23.2%N/A-88.6%$0.00$393.41M0.00660Positive NewsGap UpACONWAclarionN/A$0.03-2.2%N/A+32.5%$0.00$49,289.000.007Positive NewsGap UpAONCAmerican Oncology NetworkN/A$5.00+0.6%N/A-7.4%$0.00$1.34B0.001,520Positive NewsDHACWDigital Health AcquisitionN/A$0.04flatN/AN/A$0.00N/A0.00N/ALFMDPLifeMDN/A$26.50+5.0%N/A-1.6%$0.00$212.45M0.00230News CoveragePositive NewsGap DownHigh Trading VolumeOTRKPOntrakN/A$0.23-0.8%N/A-58.7%$0.00$10.84M0.00250Upcoming EarningsHigh Trading VolumePIIIWP3 Health PartnersN/A$0.01+1.7%N/AN/A$0.00$1.48B0.00500Gap DownTALKWTalkspaceN/A$0.09+3.0%N/A-55.4%$0.00$187.59M0.00500Gap DownNTRANatera3.0018 of 5 stars$140.65-0.5%$178.12+26.6%+48.5%$19.01B$1.70B-79.913,020Analyst ForecastPositive NewsGap DownFMSFresenius Medical Care2.9912 of 5 stars$24.75-0.6%$25.30+2.2%+24.6%$14.52B$19.34B20.45123,200Positive NewsGap DownHIMSHims & Hers Health3.7041 of 5 stars$31.04+5.0%$37.31+20.2%+84.2%$6.90B$1.48B70.54650Analyst ForecastInsider TradeGap DownHigh Trading Volume Remove Ads Related Companies and Tools Related Companies ACONW Alternatives AONC Alternatives DHACW Alternatives LFMDP Alternatives OTRKP Alternatives PIIIW Alternatives TALKW Alternatives NTRA Alternatives FMS Alternatives HIMS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TOIIW) was last updated on 4/11/2025 by MarketBeat.com Staff From Our PartnersTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredAll Signs Point To Collapse - 401(k)s/IRAs /Are DoomedRetiring? Not so Fast..Hold Onto Your Bootstraps For A Long Road AheadAmerican Hartford Gold | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Oncology Institute, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oncology Institute With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
